Reduced angiotensin II induced vascular reactivity in chronic renal failure

References

• Sørensen S. S., Danielsen H., Jespersen B., Pedersen E. B. Hypotension in end-stage renal disease: effect of postural change, exercise and angiotensin II infusion on blood pressure and plasma concentrations of antiotensin II, aldosterone and arginine vasopressin in hypotensive patients with chronic renal failure treated by dialysis. Clin Nephrol 1986; 26: 288–96
   PubMed Web of Science ®Google Scholar
• Aalkjær C., Pedersen E. B., Danielsen H., Fjeldborg O., Jespersen B., Kjær T., Sørensen S. S., Mulvany M. J. Morphological and functional characteristics of isolated resistance vessels in advanced uraemia. Clin Sci 1986; 71: 657–63
   Web of Science ®Google Scholar
• Weidmann P., Massry S. G., Coburn J. W., Maxwell M. H., Atleson J., Kleeman C. R. Blood pressure effects of acute hypercalcemia. Studies in patients with chronic renal failure. Ann Intern Med 1972; 76: 741–5
   PubMed Web of Science ®Google Scholar
• McCarron D. A., Pingree P. A., Rubin R. J., Gaucher S. M., Molitch M., Krutzik S. Enhanced parathyroid function in essential hypertension: A homeostatic response to a urinary calcium leak. Hypertension 1980; 2: 162–8
   PubMed Web of Science ®Google Scholar
• McCarron D. A. Low serum concentrations of ionized calcium in patients with hypertension. N Engl J Med 1982; 307: 226–8
   PubMed Web of Science ®Google Scholar
• Kappelgaard A. M., Damkjaer Nielsen M., Giese J. Measurement of angiotensin II in human plasma: technical modification and practical experience. Clin Chim Acta 1976; 67: 299–306
   PubMed Web of Science ®Google Scholar
• Rask-Madsen J., Bruusgaard A., Munck O., Nielsen M. D., Worning H. The significance of bile acids and aldosterone for the electrical hyper-polarization of human rectum in obese patients treated with intestinal by-pass operation. Scand J Gastroenterol 1974; 9: 417–26
   PubMed Web of Science ®Google Scholar
• Pedersen E. B., Danielsen H., Spencer E. S. Effect of indapamide on renal plasma flow, glomerular filtration rate, and arginine-vasopressin in plasma in essential hypertension. Eur J Clin Pharmacol 1984; 26: 543–7
   PubMed Web of Science ®Google Scholar
• Robertson G. L., Mahr E. A., Athar S., Sinha T. Development and clinical application of a new method for the radio-immunoassay of arginine vasopressin in human plasma. J Clin Invest 1973; 52: 2340–53
   PubMed Web of Science ®Google Scholar
• Christensen N. J., Vestergaard P., Sørensen T., Rafaelsen O. J. Cerebrospinal fluid adrenaline and noradrenaline in depressed patients. Acta Psychiatr Scand 1980; 61: 178–82
   PubMed Web of Science ®Google Scholar
• Siggaard-Andersen O., Thode J., Fogh-Andersen N. Nomograms for calculating the concentration of ionized calcium of human blood plasma from total calcium, total protein and/or albumin, and pH. Scand J Clin Lab Invest 1983; 43 (: 57–63, Suppl. 165)
   Web of Science ®Google Scholar
• McCaa R. E., Read V. H., Cowley A. W., Bower J. D., Smith G. V., McCaa C. S. Influence of acute stimuli on plasma aldosterone concentration in anephric man and kidney allograft recipients. Circ Res 1973; 33: 313–22
   PubMed Web of Science ®Google Scholar
• Tajiri M., Aizawa Y., Sakai S., Imai K., Hirasawa Y. Vascular responsiveness and body fluid status in patients on chronic hemodialysis. J Dialysis 1980; 4 (: 167–77, Suppl. 4)
   PubMed Web of Science ®Google Scholar
• Purdy R. E., Weber M. A., Drayer J. I. Vasoconstrictor effects of aldosterone in isolated vascular tissues. Clin Exp Hypertension 1982; (A) 4 (9–10): 1583–91
   Web of Science ®Google Scholar
• Caillens H., Pruszcyznski W., Meyrier A., Ang K-S, Rousselet F., Ardaillou R. Relationship between change in volemia at constant osmolality and plasma antidiuretic hormone. Mineral Electrolyte Metab 1980; 4: 161–71
   Google Scholar
• Horký K., Šrámková J., Lachmanová R., Tomašek R., Dvořáková J. Plasma concentration of antidiuretic hormone in patients with chronic renal insufficiency on maintenance dialysis. Horm Metab Res 1979; 11: 241–6
   PubMed Web of Science ®Google Scholar
• Robertson G. L., Shelton R. L., Athar S. The osmoregulation of vasopressin. Kidney Int 1976; 10: 25–37
   PubMed Web of Science ®Google Scholar
• Maxwell D., McMurray S., Szwed J., Shelton R., Robertson G. The effect of distribution and clearance on plasma vasopressin in man. Clin Res 1976; 14: 407, A
   Google Scholar
• McGrath B. P., Ledingham J. GG, Benedict C. R. Catecholamines in peripheral venous plasma in patients on chronic haemodialysis. Clin Sci 1978; 55: 89–96
   Web of Science ®Google Scholar
• Brecht H. M., Ernst W., Koch K. M. Plasma noradrenaline levels in regular haemodialysis patients. Proc Eur Dial Transpl Ass 1976; 12: 281–9
   PubMedGoogle Scholar
• Louis W. J., Doyle A. E., Anavekar S. Plasma norepinephrine levels in essential hypertension. N Engl J Med 1973; 288: 599–601
   PubMed Web of Science ®Google Scholar
• Laederach K., Weidmann P. Plasma and urinary catecholamines as related to renal function in man. Kidney Int 1987; 31: 107–11
   PubMed Web of Science ®Google Scholar
• Botey A., Gaya J., Montoliu J., Torras A., Rivera F., López-Pedret J., Revert L. Postsynaptic adrenergic unresponsiveness in hypotensive haemodialysis patients. Proc EDTA 1981; 18: 586–91
   Google Scholar
• Henriksen J. H., Kastrup J., Christensen N. J. Reduced plasma noradrenaline during angiotensin II-induced acute hypertension in man. Clin Sci 1985; 68: 621–4
   Web of Science ®Google Scholar
• Bolli P., Müller FB, Linder L., Raine A. EG, Resink T. J., Erne P., Kiowski W., Ritz R., Bühler FR. The vasodilator potency of atrial natriuretic peptide in man. Circulation 1987; 75: 221–8
   PubMed Web of Science ®Google Scholar
• Anderson J. V., Donckier J., Payne N. N., Beacham J., Slater J. DH, Bloom S. R. Atrial natriuretic peptide: evidence of action as a natriuretic hormone at physiological plasma concentrations in man. Clin Sci 1987; 72: 305–12
   PubMed Web of Science ®Google Scholar
• Hasegawa K., Matsushita Y., Inoue T., Morii H., Ishibashi M., Yamaji T. Plasma levels of atrial natriuretic peptide in patients with chronic renal failure. J Clin Endocrinol Metab 1986; 63: 819–22
   PubMed Web of Science ®Google Scholar
• Wilkins M. R., Wood J. A., Adu D., Lote C. J., Kendall M. J., Michael J. Change in plasma immunoreactive atrial natriuretic peptide during sequential ultrafiltration and haemodialysis. Clin Sci 1986; 71: 157–60
   Web of Science ®Google Scholar
• Uehlinger D. E., Weidmann P., Gnaedinger M. P., Shaw S., Lang R. E. Depressor effects and release of atrial natriuretic peptide during norepinephrine or angiotensin II infusion in man. J Clin Endocrinol Metab 1986; 63: 669–74
   PubMed Web of Science ®Google Scholar
• Kleinert H. D., Maack T., Atlas S. A., Januszewicz A., Sealey J. E., Laragh J. H. Atrial natriuretic factor inhibits angiotensin, norepinephrine-, and potassium-induced vascular contractility. Hypertension 1984; 6: 1143–7
   Web of Science ®Google Scholar
• Garcia R., Thibault G., Cantin M., Genest J. Effect of a purified atrial natriuretic factor on rat and rabbit vascular strips and vascular beds. Am J Physiol 1984; 247: R34–9
   PubMed Web of Science ®Google Scholar
• Pickering T. G., Gribbin B., Oliver D. O. Baroreflex sensitivity in patients on long-term haemodialysis. Clin Sci 1972; 43: 645–57
   PubMed Web of Science ®Google Scholar
• Saglikes Y., Massry S. G., Iseki K., Nadler J. L., Campese V. M. Effect of PTH on blood pressure and response to vasoconstrictor agonists. Am J Physiol 1985; 248: F674–81
   PubMed Web of Science ®Google Scholar
• Brickman A. S., Trujillo A. L., Gutin M. S., Tuck M. L. Diminished aldosterone responses to angiotensin II and adrenocorticotropin in hypocalcemic subjects: restoration of responsiveness with normocalcemia. J Clin Endocrinol Metab 1987; 64: 297–303
   PubMed Web of Science ®Google Scholar
• Zawada E. T., Bennett E. P., Stinson J. B., Ramirez G. Serum calcium in blood pressure regulation during hemodialysis. Arch Intern Med 1981; 141: 657–8
   PubMedGoogle Scholar